Egyptian International Pharmaceutical Industries Company (EIPICO) - Company Profile
EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million, as an Egyptian public shareholder company operating according to the Investment Law (No. 43/1974 modified by Law No. 32/1977).
EIPICO started production in 1985 as the Leading Company in Egypt and in the Middle East and North Africa (MENA) Region, to produce pharmaceutical products according to Good Manufacturing Practice (G.M.P.) regulations, with the aim of providing local and international markets with high-quality products at affordable prices.
EIPICO has 2 Plants built over a surface area of 120,000 m
2, which fully operate in compliance with cGMP regulations, to assure the safety and efficacy of the pharmaceutical products.
EIPICO is unique with its 9 Sterile Products Areas, which are the Largest and the Most Advanced, in Egypt and in the Middle East and North Africa (MENA) Region.
EIPICO has the First Biotechnology and Genetic Engineering Research Center in Egypt manufacturing biopharmaceutical products.
EIPICO manufactures More than 400 Pharmaceutical Products covering 25 Therapeutic Groups.
EIPICO is currently constructing EIPICO 3 factory , on 10,500 square It will be designated for Biological & Biosimilar products and A new state of the art Modular Manufacturing Facility
EIPICO 3 will be the first of its kind in Egypt and in the MENA Region, to manufacture Biosimilar & Biological products from the Cell Line all the way through Upstream & Downstream Process to reach Drug Substance as well as Drug Product.
With investments of 100 Million USD Shortly , it will produce drugs related to cancer, anemia and infertility
EIPICO holds License Agreements with a group of International Pharmaceutical Companies to produce their products locally.
EIPICO is currently the Major Provider of Antibiotics, Lyophilized Products and Spansule Capsules, to the Egyptian market.
EIPICO is ranked Number 1 in the Egyptian Ophthalmic Market, by Units.
EIPICO is the Leading Company to Export Pharmaceutical Products.EIPICO currently exports its products to More than 74 Countries around the world, including European, African, Asian, Latin American and CIS (Commonwealth of Independent States) Countries, with 26% Market Share of Egypt’s Total Pharmaceutical Products' Exports.
In 2014, the World Health Organization accredited EIPICO, as an approved supplier of one type of sterile antibiotic products, being the First Company in Egypt and the Middle East Region.
Global Accreditation
EIPICO implements all the quality standards to ensure that its products provide competitive advantages in efficacy, safety and price, worldwide.
EIPICO premises undergo regular inspections by different foreign health authorities.
EIPICO was certified and recognized as Quality Manufacturer by MHRA UK, PICs, WHO prequalified Lines, GCC, Ukrainian GMP, Romanian GMP, NFDAC, Ugandan GMP, and Ghanaian FDA authorities.
Find out more Our Values We genuinely good care for patients everywhere.We work on the quality of our products. We build high-performance teams. We work on the balance of justice, equity and rights distribution.
Read more
Chairman Message Our motto, “Yes, We Care”, reflects our assiduous effort and ongoing striving to assist healthcare systems, whether domestically or internationally, by providing high quality pharmaceutical products at reasonable prices.
Read more
Our History EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million, as an Egyptian public shareholder company operating according to the Investment Law (No. 43/1974 modified by Law No. 32/1977).
Read more